Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small platform update rather than a change to the study data displayed.
    Difference
    0.1%
    Check dated 2026-07-03T23:27:15.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a minor platform update to the history-tracking interface rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-26T20:38:17.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The record history now shows that participant recruitment has ended and the study documentation has a new revision (v3.6.0), with the prior revision (v3.5.5) removed.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:18.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new page revision, v3.5.5, was added to the history and the previous revision, v3.5.4, was removed, reflecting an update to the record history.
    Difference
    0.1%
    Check dated 2026-06-05T09:18:54.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3 revision tag and signaling a maintenance update to the page template.
    Difference
    0.1%
    Check dated 2026-05-15T03:25:50.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The history now shows a newer revision tag, v3.5.3, in place of the previous v3.5.2 entry, indicating an update to the page record.
    Difference
    0.1%
    Check dated 2026-04-30T17:26:26.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.